Stocks · Health care · Pharmaceutical Preparations

Edgewise Therapeutics, Inc.

EWTX Clue Score35
United States Fiscal year ends December CIK 0001710072 Results filed 4 Nov 2026

What the insiders did Mostly scheduled

Insider
Date
Role
Action
Shares
Price
Amount
Joanne M. Donovan
27 Mar 2026
CMO
Sold on a plan
6,735
$30.98
$208.64K
Joanne M. Donovan
27 Mar 2026
CMO
Sold on a plan
9,623
$30.98
$298.10K

What was left out

Form 4 filings counted 27
Amendments (4/A) skipped 5
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 2
Sales straight out of an exercise 29
Sales at will 2
Transactions with no price 0
Shares from compensation/vesting 608,158
History held since 30 Mar 2021